Inventor
ONICIU DANIELA CARMEN
US28 patents
⚠️ This page may combine multiple inventors who share the name “ONICIU DANIELA CARMEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ESPERVITA THERAPEUTICS INC
8 patentsUS11267778B2Mar 8, 2022
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC6 citations85
US11098002B2Aug 24, 2021
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC5 citations83
US11084773B1Aug 10, 2021
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC5 citations83
US12252467B2Mar 18, 2025
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC1 citations74
US12180151B2Dec 31, 2024
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC1 citations72
US11730712B2Aug 22, 2023
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC3 citations72
US11737995B2Aug 29, 2023
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC4 citations66
US12396972B2Aug 26, 2025
Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
ESPERVITA THERAPEUTICS INC0 citations54
CERENIS THERAPEUTICS HOLDING SA
5 patentsUS8349833B2Jan 8, 2013
Compounds, compositions and methods useful for cholesterol mobilisation
CERENIS THERAPEUTICS HOLDING SA7 citations76
US9708354B2Jul 18, 2017
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
CERENIS THERAPEUTICS HOLDING SA2 citations66
US9085585B2Jul 21, 2015
Compounds, compositions and methods useful for cholesterol mobilization
CERENIS THERAPEUTICS HOLDING SA3 citations60
US9713619B2Jul 25, 2017
Compounds, compositions and methods useful for cholesterol mobilization
CERENIS THERAPEUTICS HOLDING SA1 citations58
US9643915B2May 9, 2017
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
CERENIS THERAPEUTICS HOLDING SA1 citations45
CERENIS THERAPEUTICS HOLDING S A
3 patentsUS11376309B2Jul 5, 2022
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A7 citations84
US10328119B2Jun 25, 2019
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A8 citations83
US10322163B2Jun 18, 2019
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A8 citations83
ABIONYX PHARMA SA
3 patentsUS11998587B2Jun 4, 2024
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA1 citations71
US11969456B2Apr 30, 2024
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA1 citations71
US12364735B2Jul 22, 2025
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA0 citations61